A randomized, double-blind study on efficacy and safety of sepranolone in premenstrual dysphoric disorder

Innovations and changes in the ICD-11 classification of mental, behavioural and neurodevelopmental disorders

(2019) Geoffrey M. Reed et al.   World Psychiatry

Ongoing or previous mental disorders predispose to adverse mood reporting during combined oral contraceptive use

(2018) Hanna Bengtsdotter et al.   EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE

Treatment of premenstrual dysphoric disorder with the GABA A receptor modulating steroid antagonist Sepranolone (UC1010)—A randomized controlled trial

(2017) Marie Bixo et al.   PSYCHONEUROENDOCRINOLOGY

Women with premenstrual dysphoric disorder have altered sensitivity to allopregnanolone over the menstrual cycle compared to controls—a pilot study

(2016) Erika Timby et al.   PSYCHOPHARMACOLOGY

5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder

(2015) Pedro E Martinez et al.   NEUROPSYCHOPHARMACOLOGY

Isoallopregnanolone antagonize allopregnanolone-induced effects on saccadic eye velocity and self-reported sedation in humans

(2015) Sara K.S. Bengtsson et al.   PSYCHONEUROENDOCRINOLOGY

ISPMD consensus on the management of premenstrual disorders

(2013) Tracy Nevatte et al.   Archives of Womens Mental Health

Allopregnanolone and mood disorders

(2013) T. Bäckström et al.   PROGRESS IN NEUROBIOLOGY

Premenstrual Dysphoric Disorder: Evidence for a New Category for DSM-5

(2012) C. Neill Epperson et al.   AMERICAN JOURNAL OF PSYCHIATRY

Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus

(2011) Patrick Michael Shaughn O’Brien et al.   Archives of Womens Mental Health

Paradoxical effects of GABA-A modulators may explain sex steroid induced negative mood symptoms in some persons

(2011) T. Bäckström et al.   NEUROSCIENCE

Studies of pharmacokinetic and pharmacodynamic properties of isoallopregnanolone in healthy women

(2008) Helena Hedström et al.   PSYCHOPHARMACOLOGY